Screener
Tectonic Therapeutics TECX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $236,894 | $253,798 |
| Prepaid expenses and other current assets | 2,997 | 2,974 |
| Restricted cash | — | 587 |
| Total current assets | 239,891 | 257,359 |
| Property and equipment, net | 1,020 | 1,185 |
| Finance right-of-use assets, net | 410 | 495 |
| Operating right-of-use assets | 4,108 | 874 |
Item 1. Financial Statements.
FAQ
- What is Tectonic Therapeutics's restricted cash?
- Tectonic Therapeutics (TECX) reported restricted cash of $0 in Q1 2026.
- How has Tectonic Therapeutics's restricted cash changed year-over-year?
- Tectonic Therapeutics's restricted cash decreased by 100.0% year-over-year, from $587K to $0.
- What is the long-term trend for Tectonic Therapeutics's restricted cash?
- Over 5 years (2020 to 2025), Tectonic Therapeutics's restricted cash has grown at a 3.6% compound annual growth rate (CAGR), from $492K to $587K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Tectonic Therapeutics's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude